StockNews.com initiated coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a research note released on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright upgraded shares of Onconova Therapeutics from a neutral rating to a buy rating and set a $11.00 target price for the company […]